STOCK TITAN

[Form 4] GoodRx Holdings, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

GoodRx Holdings, Inc. (GDRX): This Form 4 discloses that on September 4, 2025 Spectrum Equity-related entities converted Class B shares into Class A on a one-for-one basis and distributed 5,983,984 Class A shares pro rata from Spectrum Equity VII, L.P. to its partners for no consideration. Related Spectrum entities also show beneficial ownership changes across multiple funds: Spectrum Equity VII, L.P. reflects 5,983,984 Class A shares acquired and later disposed of on a pro rata basis, while Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund show smaller acquired amounts (10,243 and 5,773) and subsequent sales at $4.05 per share on September 5, 2025, leaving 0 reported shares for those funds.

GoodRx Holdings, Inc. (GDRX): In questo Modulo 4 si segnala che il 4 settembre 2025 entità legate a Spectrum Equity hanno convertito le azioni di Classe B in azioni di Classe A con rapporto uno a uno e hanno distribuito 5.983.984 azioni di Classe A pro rata da Spectrum Equity VII, L.P. ai suoi soci a titolo gratuito. Altre entità correlate di Spectrum mostrano variazioni nella proprietà effettiva su più fondi: Spectrum Equity VII, L.P. registra l’acquisto di 5.983.984 azioni di Classe A poi distribuite pro rata, mentre Spectrum VII Investment Managers' Fund e Spectrum VII Co-Investment Fund indicano importi minori acquisiti (10.243 e 5.773) e successive vendite a $4,05 per azione il 5 settembre 2025, lasciando 0 azioni dichiarate per questi fondi.

GoodRx Holdings, Inc. (GDRX): Este Formulario 4 revela que el 4 de septiembre de 2025 entidades relacionadas con Spectrum Equity convirtieron acciones de Clase B en Clase A a razón de una por una y repartieron 5.983.984 acciones Clase A prorrata desde Spectrum Equity VII, L.P. entre sus socios sin contraprestación. Otras entidades vinculadas de Spectrum también muestran cambios en la propiedad beneficiaria en varios fondos: Spectrum Equity VII, L.P. refleja la adquisición de 5.983.984 acciones Clase A que luego se distribuyeron prorrata, mientras que Spectrum VII Investment Managers' Fund y Spectrum VII Co-Investment Fund registran importes menores adquiridos (10.243 y 5.773) y ventas posteriores a $4,05 por acción el 5 de septiembre de 2025, quedando con 0 acciones reportadas para esos fondos.

GoodRx Holdings, Inc. (GDRX): 이 Form 4 보고서에 따르면 2025년 9월 4일 Spectrum Equity 관련 기관들이 클래스 B 주식을 1대1 비율로 클래스 A 주식으로 전환하고 Spectrum Equity VII, L.P.로부터 파트너들에게 5,983,984주의 클래스 A 주식을 무상으로 비례 배분했습니다. 관련 Spectrum 계열사들은 여러 펀드에 걸쳐 실소유권 변동도 보고하고 있습니다. Spectrum Equity VII, L.P.는 5,983,984주의 클래스 A를 취득한 뒤 비례 배분으로 처분한 것으로 나타나며, Spectrum VII Investment Managers' Fund 및 Spectrum VII Co-Investment Fund는 소량(10,2435,773)을 취득한 후 2025년 9월 5일 주당 $4.05에 매각하여 해당 펀드들의 신고 주식 수는 0가 되었습니다.

GoodRx Holdings, Inc. (GDRX) : Ce formulaire 4 indique que le 4 septembre 2025 des entités liées à Spectrum Equity ont converti des actions de classe B en classe A au taux d’un pour un et ont distribué 5 983 984 actions de classe A pro rata depuis Spectrum Equity VII, L.P. à leurs associés sans contrepartie. D’autres entités associées de Spectrum montrent des changements de détention bénéficiaire sur plusieurs fonds : Spectrum Equity VII, L.P. enregistre l’acquisition de 5 983 984 actions de classe A ensuite réparties pro rata, tandis que Spectrum VII Investment Managers' Fund et Spectrum VII Co-Investment Fund ont acquis des montants plus modestes (10 243 et 5 773) puis vendu ces actions le 5 septembre 2025 à 4,05 $ par action, laissant 0 action déclarée pour ces fonds.

GoodRx Holdings, Inc. (GDRX): Dieses Formular 4 gibt an, dass am 4. September 2025 von Spectrum Equity verbundene Einheiten Stammaktien der Klasse B eins zu eins in Klasse A umgewandelt und 5.983.984 Klasse-A-Aktien pro rata von Spectrum Equity VII, L.P. an seine Partner ohne Gegenleistung verteilt wurden. Weitere Spectrum-nahe Einheiten zeigen Veränderungen der wirtschaftlichen Eigentümerschaft in mehreren Fonds: Spectrum Equity VII, L.P. verzeichnet den Erwerb von 5.983.984 Klasse-A-Aktien, die später pro rata veräußert wurden, während der Spectrum VII Investment Managers' Fund und der Spectrum VII Co-Investment Fund kleinere Mengen (10.243 bzw. 5.773) erworben und am 5. September 2025 zu $4,05 pro Aktie verkauft haben, womit für diese Fonds 0 gemeldete Aktien verbleiben.

Positive
  • Conversion completed: Class B shares converted to Class A on a one-for-one basis, simplifying equity class structure for the reporting entities.
  • Transparent disclosure: Filing provides clear transaction dates, quantities, and sale price ($4.05) for the dispositions, aiding investor visibility into insider activity.
Negative
  • Large distribution and disposition: A pro rata distribution of 5,983,984 Class A shares was made and affiliated funds sold shares the following day, which may be viewed as insider monetization.
  • Reported holdings reduced to zero: Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund reported sales that left 0 shares following the transactions.

Insights

TL;DR: Conversion and large pro rata distribution occurred; some affiliated funds sold converted shares the next day at $4.05, reducing reported holdings to zero.

The filing documents an internal one-for-one conversion of Class B into Class A shares and a pro rata distribution of 5,983,984 Class A shares by Spectrum Equity VII, L.P. to its partners for no consideration on September 4, 2025. Subsequent Form 4 lines show sales by affiliated funds on September 5, 2025 at $4.05 per share that reduced reported holdings to zero for those funds. For investors, this clarifies changes in insider ownership and immediate monetization by specific affiliated entities; the filing contains no financial performance data or commentary on company operations.

TL;DR: Transaction reflects ownership structure actions among Spectrum Equity entities rather than a direct operational development at GoodRx.

The report details conversion mechanics and internal distributions among Spectrum Equity VII and related entities, and identifies the individuals who may share voting/dispositive power. It notes that the general partner and management entities effected the transactions and that named managers disclaim beneficial ownership except to the extent of pecuniary interest. This is a disclosure-important governance event but appears procedural rather than signaling a change in corporate control or policy.

GoodRx Holdings, Inc. (GDRX): In questo Modulo 4 si segnala che il 4 settembre 2025 entità legate a Spectrum Equity hanno convertito le azioni di Classe B in azioni di Classe A con rapporto uno a uno e hanno distribuito 5.983.984 azioni di Classe A pro rata da Spectrum Equity VII, L.P. ai suoi soci a titolo gratuito. Altre entità correlate di Spectrum mostrano variazioni nella proprietà effettiva su più fondi: Spectrum Equity VII, L.P. registra l’acquisto di 5.983.984 azioni di Classe A poi distribuite pro rata, mentre Spectrum VII Investment Managers' Fund e Spectrum VII Co-Investment Fund indicano importi minori acquisiti (10.243 e 5.773) e successive vendite a $4,05 per azione il 5 settembre 2025, lasciando 0 azioni dichiarate per questi fondi.

GoodRx Holdings, Inc. (GDRX): Este Formulario 4 revela que el 4 de septiembre de 2025 entidades relacionadas con Spectrum Equity convirtieron acciones de Clase B en Clase A a razón de una por una y repartieron 5.983.984 acciones Clase A prorrata desde Spectrum Equity VII, L.P. entre sus socios sin contraprestación. Otras entidades vinculadas de Spectrum también muestran cambios en la propiedad beneficiaria en varios fondos: Spectrum Equity VII, L.P. refleja la adquisición de 5.983.984 acciones Clase A que luego se distribuyeron prorrata, mientras que Spectrum VII Investment Managers' Fund y Spectrum VII Co-Investment Fund registran importes menores adquiridos (10.243 y 5.773) y ventas posteriores a $4,05 por acción el 5 de septiembre de 2025, quedando con 0 acciones reportadas para esos fondos.

GoodRx Holdings, Inc. (GDRX): 이 Form 4 보고서에 따르면 2025년 9월 4일 Spectrum Equity 관련 기관들이 클래스 B 주식을 1대1 비율로 클래스 A 주식으로 전환하고 Spectrum Equity VII, L.P.로부터 파트너들에게 5,983,984주의 클래스 A 주식을 무상으로 비례 배분했습니다. 관련 Spectrum 계열사들은 여러 펀드에 걸쳐 실소유권 변동도 보고하고 있습니다. Spectrum Equity VII, L.P.는 5,983,984주의 클래스 A를 취득한 뒤 비례 배분으로 처분한 것으로 나타나며, Spectrum VII Investment Managers' Fund 및 Spectrum VII Co-Investment Fund는 소량(10,2435,773)을 취득한 후 2025년 9월 5일 주당 $4.05에 매각하여 해당 펀드들의 신고 주식 수는 0가 되었습니다.

GoodRx Holdings, Inc. (GDRX) : Ce formulaire 4 indique que le 4 septembre 2025 des entités liées à Spectrum Equity ont converti des actions de classe B en classe A au taux d’un pour un et ont distribué 5 983 984 actions de classe A pro rata depuis Spectrum Equity VII, L.P. à leurs associés sans contrepartie. D’autres entités associées de Spectrum montrent des changements de détention bénéficiaire sur plusieurs fonds : Spectrum Equity VII, L.P. enregistre l’acquisition de 5 983 984 actions de classe A ensuite réparties pro rata, tandis que Spectrum VII Investment Managers' Fund et Spectrum VII Co-Investment Fund ont acquis des montants plus modestes (10 243 et 5 773) puis vendu ces actions le 5 septembre 2025 à 4,05 $ par action, laissant 0 action déclarée pour ces fonds.

GoodRx Holdings, Inc. (GDRX): Dieses Formular 4 gibt an, dass am 4. September 2025 von Spectrum Equity verbundene Einheiten Stammaktien der Klasse B eins zu eins in Klasse A umgewandelt und 5.983.984 Klasse-A-Aktien pro rata von Spectrum Equity VII, L.P. an seine Partner ohne Gegenleistung verteilt wurden. Weitere Spectrum-nahe Einheiten zeigen Veränderungen der wirtschaftlichen Eigentümerschaft in mehreren Fonds: Spectrum Equity VII, L.P. verzeichnet den Erwerb von 5.983.984 Klasse-A-Aktien, die später pro rata veräußert wurden, während der Spectrum VII Investment Managers' Fund und der Spectrum VII Co-Investment Fund kleinere Mengen (10.243 bzw. 5.773) erworben und am 5. September 2025 zu $4,05 pro Aktie verkauft haben, womit für diese Fonds 0 gemeldete Aktien verbleiben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Spectrum Equity VII, L.P.

(Last) (First) (Middle)
140 NEW MONTGOMERY STREET, 20TH FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/04/2025 C(1) 5,983,984 A (1) 5,983,984 I By Spectrum Equity VII, L.P.(2)
Class A Common Stock 09/04/2025 C(1) 10,243 A (1) 10,243 I By Spectrum VII Investment Managers' Fund, L.P.(2)
Class A Common Stock 09/04/2025 C(1) 5,773 A (1) 5,773 I By Spectrum VII Co-Investment Fund L.P.(2)
Class A Common Stock 09/04/2025 J(3) 5,983,984 D $0 0 I By Spectrum Equity VII, L.P.(2)
Class A Common Stock 09/05/2025 S 10,243 D $4.05 0 I By Spectrum VII Investment Managers' Fund, L.P.(2)
Class A Common Stock 09/05/2025 S 5,773 D $4.05 0 I By Spectrum VII Co-Investment Fund L.P.(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class B Common Stock (1) 09/04/2025 C(1) 5,983,984 (1) (1) Class A Common Stock 5,983,984 (1) 8,881,362 I By Spectrum Equity VII, L.P.(2)
Class B Common Stock (1) 09/04/2025 C(1) 10,243 (1) (1) Class A Common Stock 10,243 (1) 15,202 I By Spectrum VII Investment Managers' Fund, L.P.(2)
Class B Common Stock (1) 09/04/2025 C(1) 5,773 (1) (1) Class A Common Stock 5,773 (1) 8,569 I By Spectrum VII Co-Investment Fund L.P.(2)
1. Name and Address of Reporting Person*
Spectrum Equity VII, L.P.

(Last) (First) (Middle)
140 NEW MONTGOMERY STREET, 20TH FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Spectrum VII Investment Managers' Fund, L.P.

(Last) (First) (Middle)
140 NEW MONTGOMERY STREET, 20TH FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Spectrum VII Co-Investment Fund, L.P.

(Last) (First) (Middle)
140 NEW MONTGOMERY STREET, 20TH FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Spectrum Equity Associates VII, L.P.

(Last) (First) (Middle)
140 NEW MONTGOMERY STREET, 20TH FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
SEA VII Management, LLC

(Last) (First) (Middle)
140 NEW MONTGOMERY STREET, 20TH FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Represents the conversion of the Issuer's Class B Common Stock ("Class B Shares") into shares of the Issuer's Class A Common Stock (the "Class A Shares") on a one-for-one basis.
2. The general partner of Spectrum Equity VII, L.P. ("SE VII") is Spectrum Equity Associates VII, L.P. ("Spectrum Equity Associates"). The general partner of each of Spectrum VII Investment Managers' Fund, L.P. ("Spectrum VII Investment Managers' Fund"), Spectrum VII Co-Investment Fund L.P. ("Spectrum VII Co-Investment Fund"), and Spectrum Equity Associates is SEA VII Management, LLC ("Management LLC"). Brion B. Applegate, Christopher T. Mitchell, Victor E. Parker, Jr., Benjamin C. Spero, Ronan Cunningham, Stephen M. LeSieur, Brian Regan and Michael W. Farrell may be deemed to share voting and dispositive power over the securities held by SE VII, Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund. Each of these individuals disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest, if any.
3. Spectrum Equity VII, L.P. made a pro rata distribution of 5,983,984 shares of Class A Shares to its general partner and limited partners for no consideration on September 4, 2025.
Spectrum Equity VII, L.P., By: Spectrum Equity Associates VII, L.P., its general partner, By: SEA VII Management, LLC, its general partner, By: /s/ Carolina A. Picazo, Name: Carolina A. Picazo, Chief Administrative Officer & Chief Compliance Officer 09/08/2025
Spectrum VII Investment Managers' Fund, L.P., By: SEA VII Management, LLC, its general partner, By: /s/ Carolina A. Picazo, Name: Carolina A. Picazo, Title: Chief Administrative Officer & Chief Compliance Officer 09/08/2025
Spectrum VII Co-Investment Fund, L.P., By: SEA VII Management, LLC, its general partner, By: /s/ Carolina A. Picazo, Name: Carolina A. Picazo, Title: Chief Administrative Officer & Chief Compliance Officer 09/08/2025
Spectrum Equity Associates VII, L.P., By: SEA VII Management, LLC, its general partner, By: /s/ Carolina A. Picazo, Name: Carolina A. Picazo, Title: Chief Administrative Officer & Chief Compliance Officer 09/08/2025
SEA VII Management, LLC, By: /s/ Carolina A. Picazo, Name: Carolina A. Picazo, Title: Chief Administrative Officer & Chief Compliance Officer 09/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for GDRX disclose on September 4–5, 2025?

The filing shows a one-for-one conversion of Class B into Class A shares and a pro rata distribution of 5,983,984 Class A shares on September 4, 2025, and affiliated funds sold certain shares on September 5, 2025 at $4.05 per share.

How many Class A shares were distributed by Spectrum Equity VII, L.P.?

Spectrum Equity VII, L.P. made a pro rata distribution of 5,983,984 Class A shares to its general partner and limited partners for no consideration on September 4, 2025.

Did any affiliated funds sell shares after the conversion and distribution?

Yes. Spectrum VII Investment Managers' Fund sold 10,243 shares and Spectrum VII Co-Investment Fund sold 5,773 shares on September 5, 2025 at $4.05 per share, with reported post-transaction holdings of 0.

Who may have voting or dispositive power over the reported securities?

The filing names Brion B. Applegate, Christopher T. Mitchell, Victor E. Parker, Jr., Benjamin C. Spero, Ronan Cunningham, Stephen M. LeSieur, Brian Regan and Michael W. Farrell as individuals who may be deemed to share voting and dispositive power over the securities held by the reporting entities.

Were any shares distributed for consideration?

No. The pro rata distribution of 5,983,984 Class A shares by Spectrum Equity VII, L.P. was made for no consideration on September 4, 2025.
Goodrx Holdings, Inc.

NASDAQ:GDRX

GDRX Rankings

GDRX Latest News

GDRX Latest SEC Filings

GDRX Stock Data

1.43B
81.98M
12.67%
62.83%
1.92%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SANTA MONICA